Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ADVB

Advanced Biomed Inc

13.48

Jul 23 • 3:04 PM ET +1.23 (10.06%)

Healthcare Diagnostics & Research Taiwan Nano NASD

Today, 9:30 AMClinical trial breakthrough news drives 29% surge in ADVB shares

Peers: BIAF ISPC NDRA NOTV MBAI XWEL MDXH PRPO QUCY XGN

Scroll to Statements

Index	-
Market Cap	22.28M
Enterprise Value	22.22M
Income	0.17M
Sales	0.00M
Book/sh	0.21
Cash/sh	0.05
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	31
IPO	Mar 06, 2025

P/E	84.69
Forward P/E	-
PEG	-
P/S	-
P/B	64.69
P/C	278.46
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	7.38
Current Ratio	7.38
Debt/Eq	0.07
LT Debt/Eq	0.00
Option/Short	No / No

EPS (ttm)	0.16
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	10.67% -12.01%
Sales past 3/5Y	- -
EPS Y/Y TTM	271.18%
Sales Y/Y TTM	-
EPS Q/Q	69.15%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	66.03%
Insider Trans	0.00%
Inst Own	0.08%
Inst Trans	-0.01%
ROA	59.90%
ROE	84.61%
ROIC	58.89%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	121.73%
SMA50	165.20%
SMA200	117.54%
Trades

Shs Outstand	1.38M
Shs Float	0.56M
Short Float	2.75%
Short Ratio	0.01
Short Interest	0.02M
52W High	18.73 -28.01%
52W Low	3.61 273.48%
Volatility	48.23% 19.33%
ATR (14)	2.17
RSI (14)	80.07
Beta	-1.19
Rel Volume	8.32
Avg Volume	1.53M
Volume	10,986,256

Perf Week	175.16%
Perf Month	163.57%
Perf Quarter	152.49%
Perf Half Y	106.35%
Perf YTD	131.03%
Perf Year	8.73%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	12.25
Price	13.48
Change	10.06%

Feb-18-26 07:00AM	Advanced Biomed Inc. Announces 1 for 20 Share Consolidation (GlobeNewswire) -10.69%
Feb-13-26 08:00AM	Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire)
Dec-31-25 10:25AM	Advanced Biomed sells Hong Kong subsidiary for $23,000 (TipRanks) -13.82%
Dec-30-25 10:17AM	Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary (GlobeNewswire)
Sep-19-25 08:30AM	Advanced Biomed Inc. Announces Launch of A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire) -17.18%
12:29PM	Loading…
Mar-07-25 12:29PM	Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering (GlobeNewswire)
Mar-06-25 09:02AM	Advanced Biomed Inc. Announces Pricing of Initial Public Offering (GlobeNewswire)

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

CFO & DirectorMr. Mingze Yin

CEO & ChairmanMr. Xiaomin Chen Ph.D.

Director of Investor Relations- Alan

SecretaryDr. Hung To Pau Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADVB

Advanced Biomed Inc

Upgrade your Finviz experience